These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12499171)

  • 21. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans.
    Sullivan DJ; Moran GP; Pinjon E; Al-Mosaid A; Stokes C; Vaughan C; Coleman DC
    FEMS Yeast Res; 2004 Jan; 4(4-5):369-76. PubMed ID: 14734017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of Candida dubliniensis in Venezuela.
    Hartung de Capriles C; Mata-Essayag S; Pérez C; Colella MT; Roselló A; Olaizola C; Abate SM
    Mycopathologia; 2005 Oct; 160(3):227-34. PubMed ID: 16205971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
    Anil S; Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review.
    White A; Goetz MB
    Clin Infect Dis; 1994 Oct; 19(4):687-92. PubMed ID: 7803633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species.
    Tsai H; Bobek LA
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2224-8. PubMed ID: 9333052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Candida dubliniensis, a new fungal pathogen.
    Gutiérrez J; Morales P; González MA; Quindós G
    J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.
    Brown DM; Jabra-Rizk MA; Falkler WA; Baqui AA; Meiller TF
    Pediatr Dent; 2000; 22(3):234-8. PubMed ID: 10846737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.
    Ellepola AN; Jayathilake JA; Sharma PN; Khan ZU
    J Investig Clin Dent; 2016 Nov; 7(4):424-430. PubMed ID: 26059506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
    Ellepola AN; Joseph BK; Samaranayake LP; Bandara HM; Khan ZU
    J Investig Clin Dent; 2016 May; 7(2):149-57. PubMed ID: 25388637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Candida dubliniensis in a prospective study of patients in the United States.
    Jabra-Rizk MA; Baqui AA; Kelley JI; Falkler WA; Merz WG; Meiller TF
    J Clin Microbiol; 1999 Feb; 37(2):321-6. PubMed ID: 9889211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida dubliniensis identification in Brazilian yeast stock collection.
    Mariano Pde L; Milan EP; da Matta DA; Colombo AL
    Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):533-8. PubMed ID: 12937769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluconazole susceptibility of Italian Candida dubliniensis clinical isolates determined by reference and simplified tests.
    Giammanco GM; Pecorella S; Distefano S; Pecoraro V; Milici ME; Pizzo G
    New Microbiol; 2001 Oct; 24(4):397-404. PubMed ID: 11718378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.
    Dronda F; Alonso-Sanz M; Laguna F; Chaves F; Martínez-Suárez JV; Rodríguez-Tudela JL; González-López A; Valencia E
    Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):446-52. PubMed ID: 8839637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
    Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
    Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals.
    Jabra-Rizk MA; Falkler WA; Merz WG; Baqui AA; Kelley JI; Meiller TF
    J Clin Microbiol; 2000 Jun; 38(6):2423-6. PubMed ID: 10835022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.